Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
                28%
                                OVERLAP
BY WEIGHT
10
                                # OF OVERLAPPING
HOLDINGS
PJP
                            29
                                HOLDINGS
                            
                                    34%
                                
                                ALSO IN PPH
                            PPH
                            27
                                HOLDINGS
                            
                                    42%
                                
                                ALSO IN PJP
                            SECTOR DRIFT (PJP minus PPH)
                OVERLAPPING HOLDINGS
                Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP  | 
                                Weight in PPH  | 
                                Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 5.4% | 21.9% | 5.4% | |
| MERCK & CO. INC. | 5.0% | 7.4% | 5.0% | |
| PFIZER INC | 5.2% | 4.8% | 4.8% | |
| JOHNSON & JOHNSON | 5.1% | 4.6% | 4.6% | |
| ABBVIE INC | 5.3% | 4.4% | 4.4% | |
PJP Overweight Relative to PPH
                | AMGEN INC | 4.9% | |
| ABBOTT LABORATORIES | 4.9% | |
| GILEAD SCIENCES INC | 4.7% | |
| UNITED THERAPEUTICS CORP | 3.8% | |
| TRAVERE THERAPEUTICS, INC. | 3.7% | |
| BIOGEN IDEC INC | 3.0% | |
| LIGAND PHARMACEUTICALS-CL B | 2.9% | |
| CORCEPT THERAPEUTICS INC | 2.9% | |
| AMNEAL PHARMACEUTICALS, INC. CLASS A | 2.9% | |
| TARSUS PHARMACEUTICALS, INC. | 2.9% | 
PJP Underweight Relative to PPH
                | ELI LILLY & CO | -16.5% | |
| NOVARTIS AG-ADR | -9.1% | |
| NOVO-NORDISK A/S-SPONS ADR | -6.7% | |
| GLAXOSMITHKLINE PLC-SPON ADR | -5.0% | |
| MCKESSON CORP | -5.0% | |
| SANOFI-AVENTIS-ADR | -4.6% | |
| ASTRAZENECA PLC-SPONS ADR | -4.4% | |
| ZOETIS INC | -4.2% | |
| CENCORA INC | -3.9% | |
| MERCK & CO. INC. | -2.4% |